EDSA

Edesa Biotech Stock Price

6.0627
-0.1373 (-2.21%)
Upgrade to Real-Time
Regular Market
6.0627
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Edesa Biotech Inc EDSA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.1373 -2.21% 6.0627 10:20:45
Close Price Low Price High Price Open Price Previous Close
5.95 6.2188 6.18 6.20
Bid Price Ask Price Spread News
5.99 6.09 0.10 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
114 12,175 $ 6.05 $ 73,719 194,873 1.58 - 19.10
Last Trade Time Type Quantity Stock Price Currency
10:20:45 150 $ 6.0627 USD

Edesa Biotech Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 58.62M 9.61M 4.69M $ 211.85k $ - -3.79 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 371.73k 6.20%

more financials information »

Edesa Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EDSA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.656.655.906.20105,502-0.5873-8.83%
1 Month8.0010.135.907.44217,634-1.94-24.22%
3 Months7.0410.155.387.72311,879-0.9773-13.88%
6 Months2.6519.102.207.241,024,0013.41128.78%
1 Year5.6919.101.587.04540,3820.37276.55%
3 Years5.1519.101.586.95458,7910.912717.72%
5 Years5.1519.101.586.95458,7910.912717.72%

Edesa Biotech Description

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.


Your Recent History
NASDAQ
EDSA
Edesa Biot..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.